Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(+)- Epicatechin1件: Epicatechin---1件: 113
2(+)-Epicatechin1件: Epicatechin---1件: 113
3(-)-Epicatechin1件: Epicatechin---2件: 86, 113
412 mg/kg GSK2402968----1件: 113
52011-2012 seasonal flu vaccine Intramuscular----2件: 3, 113
62011-2012 seasonal flu vaccine Subcutaneous----2件: 3, 113
729180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113
83 mg/kg GSK2402968----1件: 113
94-Benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione----1件: 113
104-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 113
115-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole----1件: 113
126 mg/kg GSK2402968----1件: 113
13750 mg metformin and 7.5 g L-citrulline daily p.o.2件: Citrulline,
Metformin		1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
149 mg/kg GSK2402968----1件: 113
15AAV1-gamma-sarcoglycan vector injection----1件: 113
16ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113
17ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113
18ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113
19ACE-031 0.5 mg/kg q4wk----1件: 113
20ACE-031 1.0 mg/kg q2wk----1件: 113
21ACE-083----2件: 10, 113
22Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
23Actonel Once a week 5mg film coated tablets1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113
24Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113
25Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113
26Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113
27ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113
28Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299
29Allogeneic Cardiosphere-Derived Cells (CAP-1002)1件: CAP-1002---1件: 113
30Anti-myostati----1件: 113
31Anti-Myostatin Adnectin----1件: 113
32AOC 1001----1件: 113
33AOC 1020----1件: 113
34AOC 1044----1件: 113
35Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
36Aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231
37ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
38Ataluren 1000 mg1件: Ataluren1件: D09323 --1件: 113
39Ataluren 125 mg1件: Ataluren1件: D09323 --1件: 113
40Ataluren 250 mg1件: Ataluren1件: D09323 --1件: 113
41ATYR19401件: ATYR-1940---1件: 113
42Autologous bone marrow mononuclear cell transplantation----1件: 113
43AVI-4658----1件: 113
44AVI-4658 (Eteplirsen)1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
45AVI-4658 (PMO)----1件: 113
46AVI-4658 for Injection----1件: 113
47BBP-418----1件: 113
48Betaloc ZOK 100, 95 mg----1件: 113
49Betaloc ZOK 25, 23,75 mg----1件: 113
50BIO101----1件: 113
51BISOPROLOL1件: Bisoprolol1件: D02342 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 58, 67, 86, 113
52Bisoprolol Fumarate1件: Bisoprolol1件: D02342 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 113
53Bisphosphonate treatment----2件: 113, 299
54Blood assays----1件: 113
55Blood test----6件: 36, 51, 107, 113, 162, 299
56BLS-M221件: BLS-M22---1件: 113
57BMN 044----1件: 113
58BMN 044 IV 6 mg/kg----1件: 113
59BMN 044 IV 9 mg/kg----1件: 113
60BMN 044 SC 6 mg/kg----1件: 113
61BMN 0451件: BMN-045---1件: 113
62BMN 053----1件: 113
63BMN0531件: BMN-053---1件: 113
64BMS-986089----1件: 113
65BMS-986089-01 (RO7239361) , anti-myostatin----1件: 113
66BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
67BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
68BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
69BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
70BMS-986089-01 (RO7239361), anti-myostatin----1件: 113
71BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
72BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
73BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
74BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
75BMS-986089-01, Anti-myostatin----1件: 113
76Bocidelpar1件: Bocidelpar1件: D12242 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 113
77BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
78Cabaletta1件: Trehalose---2件: 18, 113
79Calcichew D3 Forte----1件: 113
80CALCIFEDIOL1件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 113
81Canakinumab1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
82Canakinumab Injection [Ilaris]1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 113
83CAP-10021件: CAP-1002---1件: 113
84Cardicor----1件: 113
85Cardicor (Merck brand)----1件: 113
86Cardiovascular profile----1件: 113
87Carvedilol1件: Carvedilol1件: D00255 5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬		13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 86, 113, 210
88CASIMERSEN1件: Casimersen1件: D11988 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
89CAT-1004----1件: 113
90Chronic Corticosteroid Therapy----1件: 113
91Cialis 10 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
92Cialis 2.5 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
93Cialis 20 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
94Cialis 5 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
95Citrulline1件: Citrulline---2件: 86, 113
96Coenzyme Q101件: Ubidecarenone1件: D01065 --11件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215
97Coenzyme Q10 and Lisinopril2件: Lisinopril,
Ubidecarenone		3件: D00362 ,
D01065 ,
D08131 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113
98Corticosteroids----12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300
99Cosintropina acetato----1件: 113
100Cosyntropin1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 113, 145
101Cosyntropin acetate2件: Acetate,
Tetracosactide		1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
102Cr13C----1件: 113
103CRD-TMH-001----1件: 113
104CRD007----1件: 113
105Creatine1件: Creatine---11件: 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201
106Creatine Monohydrate1件: Creatine---4件: 2, 8, 113, 156
107Creatine-13C1件: Creatine---1件: 113
108Cyclosporin1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326
109Cyclosporin A1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164
110Decortin----2件: 46, 113
111DEFLAN*10CPR 6MG----1件: 113
112Deflazacort1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113
113Deflazacort 6 mg Tablets1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
114Dehydroepiandrosterone1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 49, 53, 83, 96, 113
115Dehydroepiandrosterone 100 and 400 mg1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
116DELTACORTENE*20CPR 5MG----3件: 49, 97, 113
117DEXMEDETOMIDINE1件: Dexmedetomidine1件: D00514 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280
118DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301
119DILATREND----1件: 113
120Dosing Extension----1件: 113
121Drisapersen1件: Drisapersen1件: D10114 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
122DRISAPERSEN SODIUM1件: Drisapersen1件: D10114 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
123Drug:----3件: 14, 46, 113
124DS-5141b----1件: 113
125DYNE-101----1件: 113
126DYNE-251----1件: 113
127EDASALONEXENT1件: Edasalonexent1件: D12181 1件: RELA 💬76件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
128EDG-5506----1件: 113
129EDG-5506 Dose 1----1件: 113
130EDG-5506 Dose 2----1件: 113
131EDG-5506 Dose 3----1件: 113
132EDG-5506 Dose 4----1件: 113
133EDG-5506 Dose 5----1件: 113
134EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299
135EMD 87580----1件: 113
136EMEA/H/C/000638----1件: 113
137EMFLAZA® (DEFLAZACORT)1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
138EN001----2件: 10, 113
139EnaHexal----1件: 113
140EnaHexal®, 10mg----1件: 113
141Enalapril1件: Enalapril1件: D07892 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬6件: 19, 46, 66, 113, 210, 222
142EnalHexal®, 5 mg----1件: 113
143End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----2件: 113, 299
144EPA----6件: 8, 46, 48, 49, 113, 301
145EPA and DHA----1件: 113
146Epicatechin1件: Epicatechin---2件: 86, 113
147Epigallocatechin1件: Epigallocatechin---5件: 8, 13, 28, 85, 113
148Epigallocatechin-Gallate1件: Epigallocatechin---1件: 113
149Eplerenone1件: Eplerenone1件: D01115 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215
150ERX-963----1件: 113
151Esomeprazole1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
152Esomeprazolo----1件: 113
153ETEPLIRSEN1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
154Eteplirsen Injection1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
155Eucardic----1件: 113
156EV substance code: SUB188638----1件: 113
157Exondys 511件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
158EXONDYS 51™1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
159Ezutromid1件: Ezutromid---1件: 113
160FG-3019----3件: 85, 113, 222
161Filgrastim1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
162Flavocoxid----1件: 113
163Fordadistrogene movaparvovec1件: Fordadistrogene movaparvovec---1件: 113
164FTX-1821----1件: 113
165Genetic characterization----1件: 113
166Gentamicin1件: Gentamicin1件: D08013 --3件: 36, 113, 299
167Gentamicin infusions twice a week for six months1件: Gentamicin1件: D08013 --1件: 113
168Givinostat1件: Givinostat---2件: 107, 113
169Givinostat (hydrochloride monohydrate)1件: Givinostat---1件: 113
170GIVINOSTAT (hyrochloride monohydrate)1件: Givinostat---1件: 113
171Givinostat (idrocloruro monoidrato)1件: Givinostat---1件: 113
172Glutamine1件: L-Glutamine1件: D00015 --8件: 87, 89, 96, 97, 113, 222, 245, 299
173GNT0004----1件: 113
174GNT0006----1件: 113
175Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
176GOLODIRSEN1件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
177Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]1件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
178Granulocyte colony-stimulating factor (Filgrastim)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 113
179GSK2402968----1件: 113
180GSK2402968 3mg/kg/week----1件: 113
181GSK2402968 6 mg/kg/week----1件: 113
182GSK2402968 6mg/kg/week----1件: 113
183Guanidine1件: Guanidine---1件: 113
184H44AON188----1件: 113
185H51AON23----1件: 113
186Haemostasis tests----1件: 113
187HIDROFEROL----1件: 113
188Hidroferol®----1件: 113
189HLA-identical allogeneic mesoangioblasts----1件: 113
190HMABs----1件: 113
191Hormonal profile----1件: 113
192HT-100----1件: 113
193Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---3件: 13, 96, 113
194Ibuprofen1件: Ibuprofen1件: D00126 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
195IBUPROFEN 200MG1件: Ibuprofen1件: D00126 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 113
196Idebenone1件: Idebenone1件: D01750 --6件: 6, 8, 13, 18, 113, 302
197Idebenone 150 mg film-coated tablets1件: Idebenone1件: D01750 --1件: 113
198Ifetroban1件: Ifetroban1件: D04500 1件: TBXA2R 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬2件: 85, 113
199IGF-1----1件: 113
200Inflammatory profile----1件: 113
201IONIS-DMPKRx----1件: 113
202Isosorbide1件: Isosorbide dinitrate1件: D00516 --1件: 113
203ISOSORBIDE DINITRATE2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
204Isosorbide Dinitrate 20 mg2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
205Isosorbide Dinitrate 40 mg1件: Isosorbide dinitrate1件: D00516 --1件: 113
206Isosorbide Dinitrate 60 mg2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
207Isosorbide Dinitrate 80 mg2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
208ITF2357----4件: 96, 107, 113, 267
209ITF2357 10 mg/mL----1件: 113
210KETAMINE1件: Ketamine1件: D08098 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215
211L-arginine1件: Arginine1件: D02982 --8件: 46, 67, 78, 96, 97, 98, 113, 299
212L-Citrulline and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
213L-Glutamine1件: L-Glutamine1件: D00015 --2件: 113, 299
214Laboratory Tests----2件: 113, 256
215Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----1件: 113
216LION-101 dose level 1----1件: 113
217LION-101 dose level 2----1件: 113
218Lisinopril1件: Lisinopril2件: D00362 ,
D08131 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 19, 46, 49, 66, 67, 113, 222
219Lonafarnib1件: Lonafarnib1件: D04768 2件: FNTA,
FNTB 💬		1件: Terpenoid backbone biosynthesis 💬2件: 113, 333
220Losartan1件: Losartan1件: D08146 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
221LOSMAPIMOD1件: Losmapimod1件: D09639 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬		62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬2件: 113, 222
222Lucen----1件: 113
223Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
224Metabolic profile----1件: 113
225Metformin1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
226Metformin 500mg1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
227Metformin and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
228METFORMINA1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬2件: 67, 113
229METFORMINA - 500 30 COMPRESSE 500 MG1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
230Methylphenidate1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
231MetoHEXAL® Succ ® 23,75 mg Retardtabletten----1件: 113
232MetoHEXAL® Succ ® 47,5 mg Retardtabletten----1件: 113
233MetoHEXAL® Succ ® 95 mg Retardtabletten----1件: 113
234Metoprolol1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
235Metoprolol succinate1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 113, 193
236Mexiletine1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114
237Mexiletine 167 mg1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 113
238MNK-1411----1件: 113
239Monocytes and megacaryocytes culture and RNA extraction----1件: 113
240Moxifloxacin1件: Moxifloxacin1件: D08237 --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
241Moxifloxacin Hydrochloride1件: Moxifloxacin1件: D08237 --2件: 113, 299
242MYO-0291件: Stamulumab1件: D05917 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 113
243Myoblast autologous graft----1件: 113
244Myoblast transplantation----1件: 113
245Myoblastes autologues----1件: 113
246MYODM----1件: 113
247N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine---1件: 113
248N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate1件: Guanidine---1件: 113
249Nanosuspension)----1件: 113
250Nebivolol1件: Nebivolol1件: D05127 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 17, 85, 113, 167
251Needle biopsy of the vastus lateralis muscle----1件: 113
252Nitrate1件: Nitrate1件: D02313 --4件: 58, 67, 113, 299
253Non invasive prenatal diagnosis----3件: 8, 113, 206
254NPC-14----1件: 113
255NS-065/NCNP-01----1件: 113
256NS-089/NCNP-02----1件: 113
257Nébivolol----1件: 113
258Oligomero morfolino fosforodiamidato per skipping dell’esone 45----1件: 113
259Oligomero morfolino fosforodiamidato per skipping dell’esone 53----1件: 113
260Omigapil1件: Omigapil---1件: 113
261Oxatomide1件: Oxatomide1件: D01773 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113
262Oxatomide (tinset)1件: Oxatomide1件: D01773 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113
263P-188 NF----1件: 113
264PAMREVLUMAB1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113
265Pamrevlumab (FG-3019)1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬1件: 113
266PB1046 Injection----1件: 113
267PEMIROLAST1件: Pemirolast1件: D07476 --1件: 113
268Pending----6件: 13, 19, 96, 97, 113, 302
269Pentoxifylline1件: Pentoxifylline1件: D00501 --12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
270Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113
271Perindopril1件: Perindopril1件: D03753 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222
272Perindopril 2mg Tablets1件: Perindopril1件: D03753 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113
273PF-062526161件: Domagrozumab1件: D11047 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 113
274PF-06939926----1件: 113
275Phase 1, SQY51----1件: 113
276Phase 2a, SQY51 (cohort 1)----1件: 113
277Phase 2a, SQY51 (cohort 2)----1件: 113
278Phase 2a, SQY51 (cohort 3)----1件: 113
279Phosphorodiamidate Morpholino Oligomer----1件: 113
280Phosphorodiamidate morpholino oligomer for exon 45 skipping----1件: 113
281Phosphorodiamidate morpholino oligomer for exon 53 skipping----1件: 113
282Pitolisant1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193
283Pitolisant Oral Tablet1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
284Powder for Oral Suspension)----1件: 113
285PRD2175434----1件: 113
286PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
287Prednison----3件: 46, 84, 113
288Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
289Prednisone 5 mg tablets1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
290Prednisone plus exercise1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
291Prednisone with daily edasalonexent2件: Edasalonexent,
Prednisone		2件: D00473 ,
D12181 		2件: NR3C1,
RELA 💬		77件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
292PRO044----1件: 113
293PRO044 IV----1件: 113
294PRO044 IV 6 mg/kg----1件: 113
295PRO044 IV 9 mg/kg----1件: 113
296PRO044 SC----1件: 113
297PRO044 SC 6 mg/kg----1件: 113
298PRO0451件: BMN-045---1件: 113
299PRO045, 0.15 mg/kg/week1件: BMN-045---1件: 113
300PRO045, 1.0 mg/kg/week1件: BMN-045---1件: 113
301PRO045, 3.0 mg/kg/week1件: BMN-045---1件: 113
302PRO045, 6.0 mg/kg/week1件: BMN-045---1件: 113
303PRO045, 9.0 mg/kg/week1件: BMN-045---1件: 113
304PRO045, selected dose1件: BMN-045---1件: 113
305PRO051----1件: 113
306PRO053----1件: 113
307Protein-carbohydrate supplementation----1件: 113
308Provigil1件: Modafinil1件: D01832 --2件: 13, 113
309PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE1件: Modafinil1件: D01832 --1件: 113
310PS188----1件: 113
311PS188 (company code)----1件: 113
312PS220----1件: 113
313PS524----1件: 113
314PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----1件: 113
315PTC124----4件: 19, 113, 246, 299
316RAAV1.CMV.huFollistatin344----2件: 15, 113
317RAAV1.CMV.huFollistin344----1件: 113
318RAAV1.tMCK.human-alpha-sarcoglycan- First cohort----1件: 113
319RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort----1件: 113
320RAAV2.5-CMV-minidystrophin (d3990)----1件: 113
321RAAV8-hMD1----1件: 113
322RAAV9-CK8-h-µD51件: Zildistrogene varoparvovec---1件: 113
323RAAV9-hFKRPco_miR-208a----1件: 113
324RAAVrh74.MCK.GALGT2----1件: 113
325RAAVrh74.MCK.micro-Dystrophin----1件: 113
326Ramipril1件: Ramipril1件: D00421 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257
327Ranolazine1件: Ranolazine1件: D05700 --6件: 2, 58, 86, 96, 113, 114
328Raxone1件: Idebenone1件: D01750 --1件: 113
329RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE1件: Idebenone1件: D01750 --1件: 113
330Recombinant human anti-GDF-8 antibody----1件: 113
331Regimen Selection Phase Group 1 (COMPLETED)----1件: 113
332Regimen Selection Phase Group 2----1件: 113
333Regimen Selection Phase Group 3----1件: 113
334Resveratrol1件: Resveratrol---6件: 2, 8, 18, 89, 97, 113
335Revatio1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬3件: 85, 86, 113
336RGX-202----1件: 113
337RhIGF-I/rhIGFBP-31件: rhIGFBP-3---1件: 113
338RhIGFBP-31件: rhIGFBP-3---2件: 113, 195
339Rimeporide1件: Rimeporide---1件: 113
340Risedronate1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 46, 50, 66, 96, 107, 113, 274
341RISEDRONATE SODIUM1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬4件: 50, 107, 113, 274
342RNA extraction----1件: 113
343RO7204239----2件: 3, 113
344RO7239361----1件: 113
345RO7239361 (BMS-986089)----1件: 113
346RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
347RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
348RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
349RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
350Sandimmun Optoral----2件: 53, 113
351ScAAV9.U7.ACCA----1件: 113
352SGT-001----1件: 113
353Sildenafil1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
354Sleep parameters----1件: 113
355SMT C1100----1件: 113
356SMT C1100 (F5----1件: 113
357SMT C1100 (F5)----1件: 113
358SMT C1100 (F6----1件: 113
359SMT C1100 (F6)----1件: 113
360SNT-MC17----1件: 113
361Sodium Nitrate2件: Nitrate,
Sodium nitrate		1件: D02313 --2件: 58, 113
362Sodium Nitrate - double dose2件: Nitrate,
Sodium nitrate		1件: D02313 --1件: 113
363SomatoKine/IPLEX----1件: 113
364Somatropin1件: Somatotropin---19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
365Spironolactone1件: Spironolactone1件: D00443 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬8件: 46, 58, 67, 86, 113, 210, 218, 225
366SRP-4045----1件: 113
367SRP-4053----1件: 113
368SRP-5051----1件: 113
369SRP-9001----1件: 113
370SRP-90031件: SRP-9003---1件: 113
371SRP-9004----1件: 113
372Stem Cell----2件: 2, 113
373Stem Cells----5件: 2, 4, 46, 96, 113
374Sunphenon----2件: 13, 113
375Sunphenon EGCG1件: Epigallocatechin gallate---3件: 13, 17, 113
376Sustanon----1件: 113
377Sustanon (testosterone)1件: Testosterone1件: D00075 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
378Sustanon 250----1件: 113
379Suvodirsen----1件: 113
380Synacthen Ampoules 250 mcg----1件: 113
381Synacthen Ampoules 250 microgrammi----1件: 113
382Tacrolimus1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
383Tadalafil1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 84, 86, 113, 210
384Tadalafil 20 MG1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113
385Tadalafil and Sildenafil2件: Sildenafil,
Tadalafil		2件: D02008 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113
386TAMOX----1件: 113
387Tamoxifen1件: Tamoxifen1件: D08559 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 2, 113, 227
388Tamoxifen 20mg Hexal® Filmtabletten1件: Tamoxifen1件: D08559 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
389TAMOXIFEN CITRATE1件: Tamoxifen1件: D08559 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
390TAS-205----1件: 113
391Tehalose 30gr----1件: 113
392Temerit----1件: 113
393Testosterone1件: Testosterone1件: D00075 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬8件: 1, 2, 3, 13, 60, 76, 78, 113
394Testosterone decanoate2件: Testosterone,
Testosterone decanoate		2件: D00075 ,
D08573 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
395Testosterone Enanthate2件: Testosterone,
Testosterone enanthate		2件: D00075 ,
D00958 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
396Testosterone isocaproate2件: Testosterone,
Testosterone isocaproate		1件: D00075 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
397Testosterone phenylpropionate2件: Testosterone,
Testosterone phenylpropionate		2件: D00075 ,
D08574 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
398Testosterone propionate2件: Testosterone,
Testosterone propionate		2件: D00075 ,
D00959 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
399Tetracosactide1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 83, 113, 145, 222
400TETRACOSACTIDE ESACETATO1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
401TETRACOSACTIDE HEXAACETATE1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
402Tideglusib1件: Tideglusib---2件: 5, 113
403Tinset----1件: 113
404To be determined----2件: 96, 113
405Tranilast1件: Tranilast1件: D02027 --4件: 46, 84, 106, 113
406Translarna1件: Ataluren1件: D09323 --1件: 113
407Translarna 1000 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
408Translarna 125 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
409Translarna 250 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
410Treatment Phase Group 4----1件: 113
411Treatment taken----1件: 113
412Trehalose1件: Trehalose---3件: 2, 6, 113
413TRIATEC----1件: 113
414Umbilical Cord Based Allogenic Mesenchymal Stem Cell----1件: 113
415Umbilical Cord Mesenchymal Stem Cell----1件: 113
416Umbilical cord mesenchymal stem cells----5件: 13, 46, 57, 97, 113
417Vamarolone----1件: 113
418Vamorolone1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 97, 113
419Vamorolone 0.25 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
420Vamorolone 0.25 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
421Vamorolone 0.75 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
422Vamorolone 0.75 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
423Vamorolone 2.0 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
424Vamorolone 2.0 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
425Vamorolone 6.0 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
426Vamorolone 6.0 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
427VBP15----1件: 113
428VILTOLARSEN1件: Viltolarsen1件: D11528 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
429Vit C Vit E Zn Se----1件: 113
430Vyondys 531件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
431WVE-210201----1件: 113
432WVE-210201 (suvodirsen)----1件: 113
433Xeomin1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 5, 6, 7, 13, 15, 17, 113
434Zn----2件: 113, 299